找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of the Breast and Axilla in the Neoadjuvant Setting; Atilla Soran,Faina Nakhlis Book 2022 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: Mottled
31#
發(fā)表于 2025-3-26 23:56:55 | 只看該作者
32#
發(fā)表于 2025-3-27 01:50:12 | 只看該作者
33#
發(fā)表于 2025-3-27 08:56:37 | 只看該作者
conomic decision making. Through in-depth analyses of concepts, data, methods, and policies, this book stimulates future studieson global pandemics and their impacts on society at different levels..978-3-030-72810-6978-3-030-72808-3Series ISSN 2523-7780 Series E-ISSN 2523-7799
34#
發(fā)表于 2025-3-27 10:16:46 | 只看該作者
35#
發(fā)表于 2025-3-27 14:41:37 | 只看該作者
Breast Cancer Imaging Pre- and Post-Neoadjuvant Systemic Therapying technology expands to include new techniques, there is a new level of understanding the advantages and efficacy of imaging when evaluating and monitoring tumor response. Imaging indications, protocols, techniques, and modalities will be reviewed.
36#
發(fā)表于 2025-3-27 20:57:39 | 只看該作者
The Macroscopic and Microscopic Evaluation of Breast and Axillary Lymph Node Specimens Following Neo will also permit more meaningful and reliable comparisons across ongoing and future clinical trials. This chapter discusses the primary issues and common challenges encountered in the macroscopic and microscopic evaluation of breast and axillary lymph node specimens following NAST.
37#
發(fā)表于 2025-3-27 23:18:38 | 只看該作者
38#
發(fā)表于 2025-3-28 02:48:34 | 只看該作者
Book 2022atients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medica
39#
發(fā)表于 2025-3-28 08:30:42 | 只看該作者
Neoadjuvant Therapy for Breast Canceriated with long-term prognosis, and a pathological complete response to systemic therapy is associated with an extremely favorable disease-free and overall survival. Neoadjuvant systemic therapy should be offered to appropriate surgical candidates based on the clinical parameters of newly diagnosed invasive breast cancer.
40#
發(fā)表于 2025-3-28 10:52:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 07:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
抚顺市| 兴文县| 改则县| 兴安盟| 扬中市| 蚌埠市| 大荔县| 弥勒县| 镇坪县| 莱州市| 盐城市| 泾川县| 湖北省| 舒城县| 峨眉山市| 贵溪市| 泾阳县| 和平区| 宜春市| 博罗县| 延安市| 遵义市| 石渠县| 玛曲县| 太原市| 衢州市| 资溪县| 方山县| 鄂托克旗| 邵东县| 德保县| 泸定县| 汝南县| 玉林市| 蓬安县| 紫金县| 神农架林区| 隆子县| 宜宾县| 临沭县| 昆山市|